The win ratio approach for composite endpoints: practical guidance based on previous experience

B Redfors, J Gregson, A Crowley… - European Heart …, 2020 - academic.oup.com
The win ratio was introduced in 2012 as a new method for examining composite endpoints
and has since been widely adopted in cardiovascular (CV) trials. Improving upon …

Interventions for preoperative smoking cessation

T Thomsen, N Villebro… - Cochrane database of …, 2014 - cochranelibrary.com
Background Smokers have a substantially increased risk of postoperative complications.
Preoperative smoking intervention may be effective in decreasing this incidence, and …

Effect of early treatment with ivermectin among patients with Covid-19

G Reis, EASM Silva, DCM Silva… - … England Journal of …, 2022 - Mass Medical Soc
Background The efficacy of ivermectin in preventing hospitalization or extended observation
in an emergency setting among outpatients with acutely symptomatic coronavirus disease …

Early treatment with pegylated interferon lambda for Covid-19

G Reis, EAS Moreira Silva… - … England Journal of …, 2023 - Mass Medical Soc
Background The efficacy of a single dose of pegylated interferon lambda in preventing
clinical events among outpatients with acute symptomatic coronavirus disease 2019 (Covid …

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman… - Bmj, 2013 - bmj.com
High quality protocols facilitate proper conduct, reporting, and external review of clinical
trials. However, the completeness of trial protocols is often inadequate. To help improve the …

Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular …

PS Roshanov, B Rochwerg, A Patel, O Salehian… - …, 2017 - pubs.asahq.org
Background The effect on cardiovascular outcomes of withholding angiotensin-converting
enzyme inhibitors or angiotensin II receptor blockers in chronic users before noncardiac …

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

SJ Pocock, CA Ariti, TJ Collier… - European heart journal, 2012 - academic.oup.com
The conventional reporting of composite endpoints in clinical trials has an inherent limitation
in that it emphasizes each patient's first event, which is often the outcome of lesser clinical …

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

C Wanner, V Krane, W März… - … England Journal of …, 2005 - Mass Medical Soc
Background Statins reduce the incidence of cardiovascular events in persons with type 2
diabetes mellitus. However, the benefit of statins in such patients receiving hemodialysis …

A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy

DJ Rouse, DG Hirtz, E Thom, MW Varner… - … England Journal of …, 2008 - Mass Medical Soc
Background Research suggests that fetal exposure to magnesium sulfate before preterm
birth might reduce the risk of cerebral palsy. Methods In this multicenter, placebo-controlled …

Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence

R Rodríguez-Gutiérrez, VM Montori - … : Cardiovascular Quality and …, 2016 - Am Heart Assoc
Background—We sought to determine the concordance between the accumulating evidence
about the impact of tight versus less tight glycemic control in patients with type 2 diabetes …